AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $457,000 | +84.3% | 58,800 | +129.7% | 0.00% | – |
| Q2 2023 | $248,000 | -48.4% | 25,602 | -41.8% | 0.00% | – |
| Q1 2023 | $481,000 | +253.7% | 43,984 | +39.1% | 0.00% | – |
| Q4 2022 | $136,000 | -64.7% | 31,615 | -38.3% | 0.00% | – |
| Q3 2022 | $385,000 | -23.5% | 51,243 | +2.4% | 0.00% | – |
| Q2 2022 | $503,000 | +25.4% | 50,046 | +54.7% | 0.00% | – |
| Q1 2022 | $401,000 | -53.7% | 32,352 | -14.6% | 0.00% | – |
| Q4 2021 | $867,000 | +86.5% | 37,885 | +80.3% | 0.00% | – |
| Q3 2021 | $465,000 | -89.9% | 21,014 | -94.1% | 0.00% | -100.0% |
| Q2 2021 | $4,624,000 | +42.5% | 356,818 | +42.8% | 0.00% | 0.0% |
| Q1 2021 | $3,245,000 | +66.2% | 249,917 | +77.0% | 0.00% | 0.0% |
| Q4 2020 | $1,953,000 | +575.8% | 141,175 | +621.9% | 0.00% | – |
| Q3 2020 | $289,000 | +214.1% | 19,557 | +246.8% | 0.00% | – |
| Q2 2020 | $92,000 | +21.1% | 5,640 | +6.8% | 0.00% | – |
| Q1 2020 | $76,000 | +8.6% | 5,280 | +54.8% | 0.00% | – |
| Q4 2019 | $70,000 | +89.2% | 3,410 | -49.8% | 0.00% | – |
| Q3 2019 | $37,000 | +76.2% | 6,797 | +109.3% | 0.00% | – |
| Q2 2019 | $21,000 | -25.0% | 3,248 | -24.3% | 0.00% | – |
| Q1 2019 | $28,000 | -57.6% | 4,291 | -55.9% | 0.00% | – |
| Q4 2018 | $66,000 | -51.1% | 9,722 | -52.3% | 0.00% | – |
| Q3 2018 | $135,000 | +42.1% | 20,378 | +20.2% | 0.00% | – |
| Q2 2018 | $95,000 | +13.1% | 16,954 | +4.9% | 0.00% | – |
| Q1 2018 | $84,000 | +9.1% | 16,168 | -5.5% | 0.00% | – |
| Q4 2017 | $77,000 | -26.0% | 17,107 | +3.7% | 0.00% | – |
| Q3 2017 | $104,000 | 0.0% | 16,501 | -2.8% | 0.00% | – |
| Q2 2017 | $104,000 | -8.8% | 16,968 | +8.6% | 0.00% | – |
| Q1 2017 | $114,000 | +395.7% | 15,627 | +44.1% | 0.00% | – |
| Q4 2016 | $23,000 | -28.1% | 10,848 | +0.5% | 0.00% | – |
| Q3 2016 | $32,000 | +6.7% | 10,793 | +0.2% | 0.00% | – |
| Q2 2016 | $30,000 | -3.2% | 10,768 | -0.5% | 0.00% | – |
| Q1 2016 | $31,000 | +14.8% | 10,823 | -0.2% | 0.00% | – |
| Q4 2015 | $27,000 | -12.9% | 10,843 | -1.8% | 0.00% | – |
| Q3 2015 | $31,000 | -6.1% | 11,037 | +1.1% | 0.00% | – |
| Q2 2015 | $33,000 | -31.2% | 10,919 | -0.4% | 0.00% | – |
| Q1 2015 | $48,000 | +17.1% | 10,960 | -3.6% | 0.00% | – |
| Q4 2014 | $41,000 | -4.7% | 11,365 | -15.5% | 0.00% | – |
| Q3 2014 | $43,000 | – | 13,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |